The market expects Quest Diagnostics (DGX ... This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near ...

This widely-known consensus outlook is important in assessing ... For the last reported quarter, it was expected that Quest Diagnostics would post earnings of $2.19 per share when it actually ...

The market expects Quest Diagnostics (DGX) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus ...

The company is expected to announce its fiscal Q1 earnings results ... in advanced diagnostics. Further boosting sentiment, Quest issued an upbeat 2025 revenue outlook of $10.7 billion to $ ...

In the wake of the stock market’s selloff, 125 of the 855 US-listed stocks Morningstar covers now sit at 5 stars, signaling ...

Quest Diagnostics DGX is set to release its first-quarter 2025 results on April 22, before the market opens. The renowned diagnostics provider posted adjusted earnings per share (EPS) of $2.23 in ...

The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings ... Services industry, Quest Diagnostics Inc. has ...

BofA analyst Michael Ryskin raised the firm’s price target on Quest Diagnostics (DGX) to $198 from $190 and keeps a Buy rating on the shares.

This was the stock's second consecutive day of losses.

Barclays analyst Luke Sergott maintained a Hold rating on Quest Diagnostics (DGX – Research Report) today and set a price target of $175.00.